company background image
OPK

OPKO Health NasdaqGS:OPK Stock Report

Last Price

US$1.53

Market Cap

US$1.2b

7D

-2.5%

1Y

7.7%

Updated

04 Dec, 2023

Data

Company Financials +

OPK Stock Overview

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.

OPK fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends0/6

OPKO Health, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for OPKO Health
Historical stock prices
Current Share PriceUS$1.53
52 Week HighUS$2.24
52 Week LowUS$1.00
Beta1.84
1 Month Change13.33%
3 Month Change-12.07%
1 Year Change7.75%
3 Year Change-66.67%
5 Year Change-53.92%
Change since IPO-66.00%

Recent News & Updates

Is OPKO Health (NASDAQ:OPK) A Risky Investment?

Oct 03
Is OPKO Health (NASDAQ:OPK) A Risky Investment?

Recent updates

Is OPKO Health (NASDAQ:OPK) A Risky Investment?

Oct 03
Is OPKO Health (NASDAQ:OPK) A Risky Investment?

OPKO Health, Inc.'s (NASDAQ:OPK) 28% Share Price Surge Not Quite Adding Up

Jul 24
OPKO Health, Inc.'s (NASDAQ:OPK) 28% Share Price Surge Not Quite Adding Up

Would OPKO Health (NASDAQ:OPK) Be Better Off With Less Debt?

Jun 07
Would OPKO Health (NASDAQ:OPK) Be Better Off With Less Debt?

Is OPKO Health (NASDAQ:OPK) Using Too Much Debt?

Jan 04
Is OPKO Health (NASDAQ:OPK) Using Too Much Debt?

OPKO Health: Assessing If Significant Potential Can Be Realized

Sep 15

OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

Sep 05
OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

OPKO Health: 14%+ Short Interest Means More Volatility Over The Near Term

Jun 21

OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

Apr 29
OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

OPKO Health: A Great Long-Term Investment In Health

Apr 05

OPKO Health Is Risky But Might Make You Money

Mar 29

Analysts Have Just Cut Their OPKO Health, Inc. (NASDAQ:OPK) Revenue Estimates By 14%

Feb 27
Analysts Have Just Cut Their OPKO Health, Inc. (NASDAQ:OPK) Revenue Estimates By 14%

OPKO Health (NASDAQ:OPK) Has A Pretty Healthy Balance Sheet

Jan 12
OPKO Health (NASDAQ:OPK) Has A Pretty Healthy Balance Sheet

OPKO Health: Undervalued Opportunity

Dec 23

OPKO Health: Bullish Case Still Intact

Dec 15

We Think OPKO Health (NASDAQ:OPK) Can Stay On Top Of Its Debt

Sep 27
We Think OPKO Health (NASDAQ:OPK) Can Stay On Top Of Its Debt

OPKO Health: A Defensive, Long-Term Holding

Sep 19

Downgrade: Here's How Analysts See OPKO Health, Inc. (NASDAQ:OPK) Performing In The Near Term

Aug 03
Downgrade: Here's How Analysts See OPKO Health, Inc. (NASDAQ:OPK) Performing In The Near Term

OPKO Health: Looking For Buyers To Enter At The $3.50 Level (Support)

Jul 14

These 4 Measures Indicate That OPKO Health (NASDAQ:OPK) Is Using Debt Reasonably Well

Jun 11
These 4 Measures Indicate That OPKO Health (NASDAQ:OPK) Is Using Debt Reasonably Well

OPKO Health perks up amid insider purchase

May 26

COVID-19 testing strength helps OPKO's Q1 results surge

Apr 28

Shareholder Returns

OPKUS HealthcareUS Market
7D-2.5%-0.5%1.1%
1Y7.7%-6.2%11.7%

Return vs Industry: OPK exceeded the US Healthcare industry which returned -6.2% over the past year.

Return vs Market: OPK underperformed the US Market which returned 11.7% over the past year.

Price Volatility

Is OPK's price volatile compared to industry and market?
OPK volatility
OPK Average Weekly Movement6.1%
Healthcare Industry Average Movement7.2%
Market Average Movement6.1%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.9%

Stable Share Price: OPK is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: OPK's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19914,196Phil Frosthttps://www.opko.com

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency.

OPKO Health, Inc. Fundamentals Summary

How do OPKO Health's earnings and revenue compare to its market cap?
OPK fundamental statistics
Market CapUS$1.18b
Earnings (TTM)-US$207.61m
Revenue (TTM)US$866.93m

1.4x

P/S Ratio

-5.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
OPK income statement (TTM)
RevenueUS$866.93m
Cost of RevenueUS$627.24m
Gross ProfitUS$239.69m
Other ExpensesUS$447.30m
Earnings-US$207.61m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.27
Gross Margin27.65%
Net Profit Margin-23.95%
Debt/Equity Ratio17.4%

How did OPK perform over the long term?

See historical performance and comparison